Rajiv Agarwal

897 total citations
16 papers, 640 citations indexed

About

Rajiv Agarwal is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Rajiv Agarwal has authored 16 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Rajiv Agarwal's work include Cardiac Valve Diseases and Treatments (3 papers), Coronary Interventions and Diagnostics (3 papers) and Diabetes Treatment and Management (3 papers). Rajiv Agarwal is often cited by papers focused on Cardiac Valve Diseases and Treatments (3 papers), Coronary Interventions and Diagnostics (3 papers) and Diabetes Treatment and Management (3 papers). Rajiv Agarwal collaborates with scholars based in India, United States and Greece. Rajiv Agarwal's co-authors include Laura Williams, Jin Tian, Ping Qiu, Daniel Batlle, Muralidhar Acharya, Joel Z. Melnick, Peter Kolkhof, Stefan D. Anker, George L. Bakris and Luís M. Ruilope and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and The American Journal of the Medical Sciences.

In The Last Decade

Rajiv Agarwal

15 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajiv Agarwal India 8 265 254 198 161 126 16 640
Saori Oshiro Japan 10 145 0.5× 543 2.1× 165 0.8× 201 1.2× 56 0.4× 11 821
Vittorio Ortalda Italy 9 158 0.6× 380 1.5× 114 0.6× 70 0.4× 68 0.5× 16 588
Jesús Lechuga Montenegro Spain 13 184 0.7× 497 2.0× 118 0.6× 48 0.3× 148 1.2× 50 753
Young Shin Shin South Korea 10 70 0.3× 297 1.2× 265 1.3× 137 0.9× 101 0.8× 18 628
Kazunobu Ichikawa Japan 16 96 0.4× 461 1.8× 125 0.6× 145 0.9× 93 0.7× 45 742
Denise Parodi Italy 16 196 0.7× 344 1.4× 85 0.4× 492 3.1× 167 1.3× 20 811
Nadia Stucchi Italy 10 185 0.7× 473 1.9× 61 0.3× 73 0.5× 110 0.9× 16 869
Muralidhar Acharya United States 5 76 0.3× 434 1.7× 295 1.5× 63 0.4× 90 0.7× 6 687
Youxia Liu China 13 149 0.6× 400 1.6× 66 0.3× 271 1.7× 173 1.4× 35 824
Auke H. Brantsma Netherlands 11 243 0.9× 644 2.5× 38 0.2× 402 2.5× 129 1.0× 11 1.0k

Countries citing papers authored by Rajiv Agarwal

Since Specialization
Citations

This map shows the geographic impact of Rajiv Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajiv Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajiv Agarwal more than expected).

Fields of papers citing papers by Rajiv Agarwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajiv Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajiv Agarwal. The network helps show where Rajiv Agarwal may publish in the future.

Co-authorship network of co-authors of Rajiv Agarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Rajiv Agarwal. A scholar is included among the top collaborators of Rajiv Agarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajiv Agarwal. Rajiv Agarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Georgianos, Panagiotis I. & Rajiv Agarwal. (2022). Management of hypertension in advanced kidney disease. Current Opinion in Nephrology & Hypertension. 31(4). 374–379.
2.
Tuttle, Katherine R., Adeera Levin, Masaomi Nangaku, et al.. (2022). Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials. Figshare. 2 indexed citations
3.
Bakris, George L., Meg Jardine, Zien Zhou, et al.. (2020). Renal, Cardiovascular (CV), and Safety Outcomes of Canagliflozin (CANA) According to Baseline Albuminuria: A CREDENCE Secondary Analysis. Journal of the American Society of Nephrology. 31(10S). 328–328. 1 indexed citations
4.
Bakris, George L., Rajiv Agarwal, Stefan D. Anker, et al.. (2019). Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. American Journal of Nephrology. 50(5). 333–344. 132 indexed citations
5.
Ruilope, Luís M., Rajiv Agarwal, Stefan D. Anker, et al.. (2019). Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial. American Journal of Nephrology. 50(5). 345–356. 154 indexed citations
6.
Agarwal, Rajiv, Muralidhar Acharya, Jin Tian, et al.. (2005). Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney International. 68(6). 2823–2828. 286 indexed citations
7.
Bhargava, Balram, Rajiv Agarwal, Rakesh Yadav, Vinay K. Bahl, & Subhash C. Manchanda. (1998). Percutaneous balloon aortic valvuloplasty during pregnancy: Use of the Inoue balloon and the physiologic antegrade approach. Catheterization and Cardiovascular Diagnosis. 45(4). 422–425. 1 indexed citations
8.
Agarwal, Rajiv, et al.. (1998). Long-term outcome of intracoronary microstent implantation: Lesion matched comparison with Palmaz-Schatz stent. Catheterization and Cardiovascular Diagnosis. 43(4). 397–401. 1 indexed citations
9.
Bhargava, Balram, Rajiv Agarwal, Upendra Kaul, Subhash C. Manchanda, & Harbans S. Wasir. (1997). Transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardiomyopathy. Catheterization and Cardiovascular Diagnosis. 41(1). 56–58. 12 indexed citations
10.
Agarwal, Rajiv, et al.. (1996). Timing of Plasma Exchange Therapy for Thrombotic Thrombocytopenia Purpura: A Brief Clinical Observation. The American Journal of the Medical Sciences. 311(4). 167–168. 3 indexed citations
11.
Kaul, Upendra, Rajiv Agarwal, Pradeep Jain, et al.. (1996). Management of idiopathic obstruction of the hepatic and suprahepatic inferior vena cava with a self-expanding metallic stent. Catheterization and Cardiovascular Diagnosis. 39(3). 252–257. 14 indexed citations
12.
Agarwal, Rajiv, et al.. (1996). Timing of Plasma Exchange Therapy for Thrombotic Thrombocytopenia Purpura: A Brief Clinical Observation. The American Journal of the Medical Sciences. 311(4). 167–168. 8 indexed citations
13.
Pemde, Harish, Madhulika Kabra, Rajiv Agarwal, Yogesh Jain, & V. Seth. (1995). Hematological manifestations of congenital cytomegalovirus infection. The Indian Journal of Pediatrics. 62(4). 473–477. 2 indexed citations
14.
Goel, Punit, Rajiv Agarwal, Upendra Kaul, & Harbans S. Wasir. (1995). Effects of balloon compliance on angiographic and clinical outcomes after PTCA. International Journal of Cardiology. 51(1). 1–4. 4 indexed citations
15.
Kaul, Upendra, et al.. (1995). In‐hospital outcome of percutaneous transluminal coronary angioplasty for long lesions and diffuse coronary artery disease. Catheterization and Cardiovascular Diagnosis. 35(4). 294–300. 8 indexed citations
16.
Agarwal, Rajiv, Vinay K. Bahl, & A N Malaviya. (1992). Changing spectrum of clinical and laboratory profile of infective endocarditis.. PubMed. 40(11). 721–3. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026